Research Progress in MRI of the Visual Pathway in Diabetic Retinopathy

Abstract

With an increasing incidence, diabetic retinopathy is one of the most important complications of diabetes mellitus (DM) and is also known as one of the major reasons of adult acquired blindness. It is widely accepted that the visual impairment of diabetic patients results from retinal microvascular changes. However, recent clinical experimental and neuroimaging studies suggest that the visual impairment of diabetic patients is also related to the pathophysiological changes of different parts of the visual pathway in diabetic retinopathy. Therefore, the magnetic resonance imaging (MRI) techniques have been widely used for evaluating the microstructural changes, white matter integrity, metabolite changes, and the whole or partial functional and anatomic changes in the diabetic retinopathy patients’ brains in order to fully understand the mechanism of vision loss of the diabetic retinopathy patients. This review focuses on the research progress in application of MRI of the visual pathway in diabetic retinopathy.

Keywords

diabetic retinopathy / visual pathway / visual impairment / magnetic resonance imaging

References

[1] CalderonGD, JuarezOH, HernandezGE, et al.. Oxidative stress and diabetic retinopathy: development and treatment. Eye, 2017, 64(4): 1-9

[2] Harris NwanyanwuK, TalwarN, GardnerTW, et al.. Predicting development of proliferative diabetic retinopathy. Diabetes Care, 2013, 36(6): 1562-1568

[3] LeskeMC, WuSY, HennisA, et al.. Hyperglycemia, blood pressure, and the 9-yearincidence of diabetic retinopathy: the Barbados Eye Studies. Ophthalmol, 2005, 112(5): 799-805

[4] ChewEY, DavisMD, DanisRP, et al.. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmol, 2014, 121(12): 2443-2451

[5] EstacioRO, McFarlingE, BiggerstaffS, et al.. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis, 1998, 31(6): 947-953

[6] WolfensbergerTJ, HamiltonAM. Diabetic retinopathy—an historical review. Semin Ophthalmol, 2001, 16(1): 2-7

[7] SaaddineJB, HoneycuttAA, NarayanKM, et al.. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol, 2008, 126(12): 1740-1747

[8] HoLC, WangB, ConnerIP, et al.. In Vivo Evaluation of White Matter Integrity and Anterograde Transport in Visual System After Excitotoxic Retinal Injury With Multimodal MRI and OCT. Invest Ophthalmol Vis Sci, 2015, 56(6): 3788-3800

[9] KancherlaS, KohlerW d, MerweY, et al.. In Vivo Evaluation of the Visual Pathway in Streptozotocin-Induced Diabetes by Diffusion Tensor MRI and Contrast Enhanced MR. PLoS One, 2016, 11(10): 1-15

[10] RoyS, AminS, RoyS. Retinal fibrosis in diabetic retinopathy. Exp Eye Res, 2016, 142(1): 71-75

[11] ShiY, HuFB. The global implications of diabetes and cancer. Lancet, 2014, 383(9933): 1947-1958

[12] SunJK, RadwanSH, SolimanAZ, et al.. Neural retinal disorganization as a robust marker of visual acuity in current and resolved diabetic macular edema. Diabetes, 2015, 64(7): 2560-2570

[13] KleinR, LeeKE, GangnonRE, et al.. The 25-year incidence of visual impairment in type 1 diabetes mellitus the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmol, 2010, 117(1): 6370

[14] EwingFM, DearyIJ, StrachanMW, et al.. Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations invision. Endoce Rev, 1998, 19(4): 462-476

[15] KarlicaD, GaletovicD, IvanisevicM, et al.. Visual evoked potential can be used to detect a prediabetic form of diabetic retinopathy in patients with diabetes mellitus type I. Coll Antropol, 2010, 34(2): 525-529

[16] WolffBE, BearseM J, SchneckME, et al.. Multifocal VEP (mfVEP) reveals abnormal neuronal delays in diabetes. Doc ophthalmol, 2010, 121(3): 189-196

[17] YamazakiH, Adachi-UsamiE, ChibaJ. Contrast thresholds of diabetic patients determined by VECP and psychophysical measurements. Acta Endocrinol (Copenh), 1982, 60(3): 386-392

[18] FernandezDC, PasquiniLA, DorfmanD, et al.. Early distal axonopathy of the visual pathway in experimental diabetes. AM J Pathol, 2012, 180(1): 303-313

[19] ChelseaSK, JeffryRA, JeffreyL, et al.. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke, 2003, 34(11): 2729-2735

[20] PattonN, AslamT, MacgillivrayT, et al.. Retinal vascular image analyses as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat, 2005, 206(4): 319-348

[21] WongTY, MosleyTH, KleinR, et al.. Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology, 2003, 61(6): 806-811

[22] BiesselsGJ, ReijmerYD. Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?. Diabetes, 2014, 63(7): 2244-2252

[23] GuptaN, AngL N d, TillyL, et al.. Human glaucoma and neural degeneration in intracranial optic nerve, later geniculate nucleus, and visual cortex. Brit J Ophthalmol, 2006, 90(6): 674-678

[24] PtitoM, SchneiderFC, PaulsonOB, et al.. Alterations of the visual pathways in congenital blindness. Exp Brain Res, 2008, 187(1): 41-49

[25] Huge SchmidtCE, LovatoJF, AmbrosiusWT, et al.. The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care, 2014, 37(12): 3244-3252

[26] WesselsAM, SimsekS, RemijnsePL, et al.. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetolog, 2006, 49(10): 2474-2480

[27] BrandsAM, BiesselsGJ, de HaanEH, et al.. The effects of type 1 diabetes on cognitive performance: a metaanalysis. Diabetes Care, 2005, 28(3): 726-735

[28] RyanCM, GeckleMO, OrchardTJ. Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro-and macrovascular complications. Diabetolog, 2003, 46(7): 940-948

[29] AntonettiDA, KleinR, GardnerTW, et al.. Diabetic retinopathy. N Engl J Med, 2012, 366(13): 1227-1239

[30] KolliasAN, UlbigMW. Diabetic retinopathy early diagnosis and effective treatment. Dtsch Arztebl Int, 2010, 107(5): 75-84

[31] BerkowitzBA, RobertsR, LuanH, et al.. Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats. Invest Ophthalmol Vis Sci, 2004, 45(7): 2391-2398

[32] WatanabeT, MichaelisT, FrahmJ. Mapping of retinal projections in the living rat using high-resolution 3D gradient-echo MRI with Mn2+-induced contrast. Magne Reson Med, 2001, 46(3): 424-429

[33] BerkowitzBA, RobertsR, StemmlerA, et al.. Impaired Apparent Ion Demand in Experimental Diabetic Retinopathy: Correction by Lipoic Acid. Invest ophth Vis Sci, 2007, 48(10): 4753-4758

[34] ModiS, BhattacharyaM, SekhriT, et al.. Assessment of the metabolic profile in type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy. J Magn Reson Imaging, 2008, 26(3): 420-425

[35] OzsoyE, DoganayS, DoganM, et al.. Ealuation of metabolite changes in visual cortex in diabetic retinopathy by MR-Spectroscopy. J Diabetes Complications, 2012, 26(3): 241-245

[36] BerkowitzBA, BansalN, WilsonCA. Non-invasive measurement of steady-state vitreous lactate concentration. NMR Biomed, 1994, 7(6): 263-268

[37] RuckerJC, BiousseV, MaoH, et al.. Detection of lactate in the human vitreous body using proton magnetic resonance spectroscopy. Arch Ophtaimol, 2003, 121(6): 909-911

[38] SahinI, AlkanA, KeskinL, et al.. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Complications, 2008, 22(4): 254-260

[39] KitajimaM, KorogiY, HiraiT, et al.. MR changes in the calcarine area resulting from retinal degeneration. AJNR, 1997, 18(7): 1291-1295

[40] DoganM, OzsoyE, DoganayS, et al.. Brain diffusionweighted imaging in diabetic patients with retinopathy. Eur Rev Med Pharmacol Sci, 2012, 16(1): 126-131

[41] LiangM, ChenX, XueF, et al.. Diffusion-weighted imaging of injuries to the visual centers of the brain in patients with type 2 diabetes and retinopathy. Exp Ther Med, 2017, 14(2): 1153-1156

[42] WangZ, LuZ, LiJ, et al.. Evaluation of apparent diffusion coefficient measurements of brain injury in type 2 diabetics with retinopathy by diffusion-weighted MRI at 3.0 T. Neuroreport, 2017, 28(2): 69-74

[43] KrabbeK, GideonP, WagnP, et al.. MR diffusion imaging of human intracranial tumours. Neuroradiology, 1997, 39(7): 483-489

[44] StahlR, DietrichO, TeipelSJ, et al.. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with Diffusion-tensor MR imaging and parallel imaging techniques. Radiology, 2007, 243(2): 483-492

[45] HajiabadiM, SamiiM, FahlbuschR, et al.. A preliminary study of the clinical application of optic pathway diffusion tensor tractography in suprasellar tumor surgery: preoperative, intraoperative, and postoperative assessment. Neurosurg, 2016, 125(3): 759-765

[46] SunSW, LiangHF, LeTQ, et al.. Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving optic nerve injury in mice with retinal ischemia. Neuroimage, 2006, 32(3): 1195-1204

[47] SongSK, SunSW, JuWK, et al.. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage, 2003, 20(3): 1714-1722

[48] KodlCT, FrancDT, RaoJP, et al.. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes, 2008, 57(6): 3083-3089

[49] FrancDT, KodlCT, MuellerBA, et al.. High connectivity between reduced cortical thickness and disrupted white matter tracts in long-standing type 1 diabetes. Diabetes, 2011, 60(1): 315-319

[50] RongW, YuZF, WeiTJ, et al.. Evaluation of changes in magnetic resonance diffusion tensor imaging of the bilateral optic tract in monocular blind rats. Int J Dev Neurosci, 2017, 59(2): 10-14

[51] ZiCQ, PingN, YuLN, et al.. Visual Pathway Lesion and Its Development During Hyperbaric Oxygen Treatment: A Bold fMRI and DTI Study. J Magn Reson Imaging, 2010, 31(5): 1054-1060

[52] CuiY, JiaoY, ChenYC, et al.. Altered spontaneous brain activity in type 2 diabetes: a resting-state functional MRI study. Diabetes, 2014, 63(2): 749-760

[53] AnurovaI, RenierLA, De VolderAG, et al.. Relationship between cortical thickness and functional activation in the early blind. Cereb Cortex, 2015, 25(8): 2035-2048

[54] van DuinkerkenE, SchoonheimMM, Sanz-ArigitaEJ, et al.. Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes, 2012, 61(7): 1814-1821